empiric antifungal
Showing 1 - 25 of 531
Antimicrobial Regimens in Microbial Keratitis: A Prospective
Recruiting
- Bacterial Keratitis
- +3 more
- Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
- +7 more
-
Alexandria, EgyptCornea Outpatient Clinic at Alexandria Main University Hospital
Dec 15, 2022
Postoperative Peritonitis Trial in France (rapid molecular diagnosis, conventional method analysis)
Recruiting
- Postoperative Peritonitis
- rapid molecular diagnosis
- conventional method analysis
-
Amiens, France
- +6 more
Jan 12, 2023
Invasive Fungal Infections Trial in Italy
Completed
- Invasive Fungal Infections
-
Bologna, Italy
- +13 more
Oct 25, 2022
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United
Completed
- Acute Myeloid Leukemia
- +27 more
- Caspofungin Acetate
- +2 more
-
Birmingham, Alabama
- +178 more
Mar 26, 2021
Keratitis, Corneal Ulcer Trial in United States (PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial
Recruiting
- Keratitis
- Corneal Ulcer
- PXL Platinum 330 system + Riboflavin 0.25% TE Solution
- Sham CXL + Artificial Tears
-
Tampa, Florida
- +7 more
Jul 13, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Neutropenia Trial in Houston (Isavuconazole)
Completed
- Acute Myeloid Leukemia
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2021
Invasive Candidiasis Trial (therapy duration)
Not yet recruiting
- Invasive Candidiasis
- therapy duration
- (no location specified)
Mar 8, 2023
Kidney Stones, Nephrolithiasis Trial in Nashville (Empiric Therapy: Diet, Empiric Therapy: Drug, Selective Therapy: Diet)
Recruiting
- Kidney Stones
- Nephrolithiasis
- Empiric Therapy: Diet
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 23, 2023
Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)
Recruiting
- Acute Myeloid Leukemia
- mitoxantrone + etoposide + gemtuzumab ozogamicin
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 9, 2022
Ventilator Associated Pneumonia, Respiratory Tract Infection Trial in Canada (Normal Saline, anidulafungin)
Terminated
- Ventilator Associated Pneumonia
- Respiratory Tract Infection
- Normal Saline
- anidulafungin
-
Hamilton, Ontario, Canada
- +5 more
Jan 28, 2021
Septic Patients in the Intensive Care Unit
Not yet recruiting
- Septic Patients Admitted to the ICU
- empiric antibiotic therapy
-
Kfar Saba, IsraelMeir Medical Center
Jun 20, 2023
Hemorrhage, Trauma, Hypocalcemia Trial (Calcium Gluconate)
Not yet recruiting
- Hemorrhage
- +3 more
- Calcium Gluconate
- (no location specified)
Jul 11, 2023
Acute Lymphoblastic Leukemia, Adult, Invasive Fungal Infections Trial in Rome (observation of invasive fungal infections)
Recruiting
- Acute Lymphoblastic Leukemia, Adult
- Invasive Fungal Infections
- observation of invasive fungal infections
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Feb 20, 2023
Invasive Candidiasis Trial in France (Biomarker strategy, Routine strategy)
Recruiting
- Invasive Candidiasis
- Biomarker strategy
- Routine strategy
-
Arras, France
- +9 more
Aug 18, 2022
Antimicrobial Peptides Against Fungal Infection
Not yet recruiting
- Fungal Infection
- (no location specified)
May 6, 2022
De-escalation - Antifungal Treatment Immunocompromised Patients
Recruiting
- Invasive Fungal Disease
- Critical Illness
-
Lille, FranceCHU Lille
Oct 14, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Respiratory Infection Trial in Wien (Respiratory Panel PCR Sputum)
Recruiting
- Respiratory Infection
- Respiratory Panel PCR Sputum
-
Wien, Österreich, AustriaKlinik Favoriten
Jun 6, 2023
Vancomycin De-escalation Therapy in Patients With Pneumonia
Active, not recruiting
- Pneumonia
-
Charleston, West VirginiaCharleston Area Medical Center
Jul 19, 2022
Crohn Disease, CARD9 S12N Risk Allele Trial in Los Angeles, Rochester (Posaconazole Delayed Release Oral Tablet, Matching
Not yet recruiting
- Crohn Disease
- CARD9 S12N Risk Allele
- Posaconazole Delayed Release Oral Tablet
- Matching Placebo Tablet
-
Los Angeles, California
- +1 more
Jul 19, 2022